SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
12 references·0 citing·39 second hop
Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves (2007)Economic evaluation of hepatitis B vaccin…Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis (2007)Limitations of Acceptability …Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs (2006)Impact of Model, Methodologic…Making choices in health: who guide to cost-effectiveness analysis (2004)Making choices in health: who…New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund (2003)New tendencies and strategies…Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Thinking Outside the Box: Rec…Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)Opportunity costs and uncerta…Economic Evaluation of Vaccination Programmes (2002)Economic Evaluation of Vaccin…Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000) (2001)Economic evaluations of hepat…Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane (2001)Affordability and cost‐effect…Policy analysis of the use of hepatitis B, Haemophilus influenzae type b‐, Streptococcus pneumoniae‐conjugate and rotavirus vaccines in national immunization schedules (2000)Policy analysis of the use of…Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature (2000)Economic evaluation of commun…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United States (2006)Modelling the Epidemiology of Infectious Diseases for Decision Analysis (2011)Better health in developing countries: are sector-wide approaches the way of the future? (1998)Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis (2001)QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? (2009)The implications of benefit package design: the impact on poor Thai households of excluding renal replacement therapy (2009)United Nations Population Division (2009)Discounting and health benefits (1992)Accounting for future costs in medical cost-effectiveness analysis (1997)Economic Evaluations of Varicella Vaccination Programmes (2003)Discounting Health Effects in Pharmacoeconomic Evaluations (2005)Cost-Effectiveness Analyses of Hepatitis A Vaccine (2008)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Sensitivity Analysis in Cost-Effectiveness Studies (2011)Reducing social inequalities in health: the role of simulation modelling in chronic disease epidemiology to evaluate the impact of population health interventions (2013)Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies (2016)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Information Created to Evade Reality (ICER) (2006)Decision-analytical modelling in health-care economic evaluations (2007)Is Stacking Intervention Components Cost-Effective? An Analysis of the Incredible Years Program (2007)Methods for the economic evaluation of health care programmes (1987)The Economics of Priority Setting for Health Care : A Literature Review (2004)Cost-Effectiveness Analysis for Priority Setting (2006)Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life (1997)Use of Quality Adjusted Life Years and Life Years Gained as Benchmarks in Economic Evaluations: A Critical Appraisal (2003)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Health outcomes in economic evaluation: the QALY and utilities (2010)Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2004Making choices in health: who guide to cost-effectiveness analysis1,259 cited
  • 2002Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies404 cited
  • 2000Policy analysis of the use of hepatitis B, Haemophilus influenzae type b‐, Streptococcus pneumoniae‐conjugate and rotavirus vaccines in national immunization schedules160 cited
  • 2001Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)123 cited
  • 2002Opportunity costs and uncertainty in the economic evaluation of health care interventions115 cited
  • 2006Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs109 cited
  • 2000Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature109 cited
  • 2001Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane106 cited
  • 2002Economic Evaluation of Vaccination Programmes96 cited
  • 2007Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis89 cited
  • 2003New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund35 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work